Saving Sight: Eyes on Equity in Black & Hispanic Communities

CME/CE

This activity is jointly provided by Postgraduate Institute for Medicine and DKBmed, LLC.  

Credit Available

Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ 

Optometrists — 1.0 COPE hours 

Target Audience

This activity is intended for optometrists involved in the care of patients with diabetes. 

Educational Objectives

After completing this activity, the participant should be better able to: 

  • Assess disparities that lead to poor diabetic retinopathy (DR)/diabetic macular edema (DME) outcomes in Black and Hispanic patients with diabetes.  
  • Identify current American Academy of Ophthalmology (AAO) and American Diabetes Association (ADA) screening guidelines and determine underlying drivers for suboptimal screening rates.  
  • Evaluate current and emerging treatments for DR/DME. 

This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc., and Genentech, a member of the Roche Group. 

Faculty

Angela Elam, MD, MPH 
Assistant Professor
Associate Chair for Diversity, Equity, and Inclusion,
Department of Ophthalmology and Visual Sciences
University of Michigan Medical School

Paula R. Newsome, OD, MS, FAAO, FAAARM, CHC
Optometrist
CEO
Advantage Vision Center

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity: 

Angela Elam, MD, MPH 

  • None 

Paula R. Newsome, OD, MS, FAAO, FAAARM, CHC 

  • None 

 

The PIM planners and others have nothing to disclose. The DKBmed planners and others have nothing to disclose. 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE), DKBmed, and the Institute for Johns Hopkins Nursing. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Physician Continuing Medical Education 

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

 

COPE Statement 

Postgraduate Institute for Medicine is accredited by COPE to provide continuing education to optometrists. 

 Credit Statement: This course is COPE approved for 1.0 hours of CE credit. Activity 126278  and Course ID 85028-PB. Check with your local state licensing board to see if this counts toward your CE requirement for re-licensure. 

Method of Participation and Request for Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must: 

  1. Read the CME/CE information and faculty disclosures. 
  2. Participate in the online activity. 
  3. Submit the evaluation form. 
  4. Certificates will be available for print or download. 


Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.